Envoy Medical, Inc. (COCH) stock: key figures, P/E, revenue and dividend

Health Care · United States · ISIN US29415V1098

Price
6.50 USD
Market cap
50.18 m USD
P/E (2026)
–
P/S (2026)
–
Dividend yield
0.00 %
Net margin
–
Return on equity (ROE)
–
Return on assets (ROA)
–

Envoy Medical, Inc. financials

Fiscal year2025
Revenue241,000.00 USD
Gross profit-633,000.00 USD
Operating income-22.27 m USD
EBIT-22.17 m USD
Net income-23.76 m USD
Diluted EPS – continuing operations-1.23 USD

Full history since 2020, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Envoy Medical, Inc.

Envoy Medical, Inc., a hearing health company, provides medical technologies across the hearing loss spectrum. The company's medical technologies are designed to shift the paradigm within the hearing industry and bring providers and patients the hearing devices desire. It offers personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.